Home › Funds › Citadel Advisors › NMRA
Citadel Advisors position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)1.07M sh
Reported value held$1.82M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.17M | $29.70M | New |
| Q4 2023 | 1.85M | $30.45M | Reduce |
| Q1 2024 | 1.83M | $25.21M | Reduce |
| Q2 2024 | 892.24K | $8.77M | Reduce |
| Q3 2024 | 77.77K | $1.03M | Reduce |
| Q4 2024 | 565.37K | $5.99M | Add |
| Q1 2025 | 229.70K | $229.70K | Reduce |
| Q2 2025 | 147.19K | $107.93K | Reduce |
| Q3 2025 | 145.00K | $263.90K | Reduce |
| Q4 2025 | 553.00K | $989.88K | Add |
| Q1 2026 | 420.89K | $820.73K | Reduce |
| Q2 2026 | 1.07M | $1.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026